Chrono

The new Porsche 911 S/T: the lightest 911 of its generation

Retrieved on: 
Tuesday, August 1, 2023
Acceleration, Porsche Design, Pressure, Heart, Sport, Plaque, MSRP, S/T, Agility, RRP, GT, PCCB, Chronograph, Porsche Rennsport Reunion, Ceramica, GT3, Carbon, Element, Chrono, Movement, Certification, S, Traction, COSC, ZR, CFRP, Disc brake, Electric motor, Road, Telescopic sight, Porsche, Gold

From 1969, Porsche offered a special race version of the 911 S. Internally, these vehicles were called 911 ST.

Key Points: 
  • From 1969, Porsche offered a special race version of the 911 S. Internally, these vehicles were called 911 ST.
  • The new 911 S/T takes up the spirit of the original 911 S (ST) and transfers it to the current model generation of the Porsche 911.
  • Porsche Design is exclusively offering customers of the 911 S/T customers the option to buy a special watch: Chronograph 1 – 911 S/T.
  • The Chronograph 1 – 911 S/T will be available to order from Porsche Centers and Porsche Design Stores, and retails at $13,500 (RRP).

First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)

Retrieved on: 
Wednesday, June 8, 2022
Analgesic, Treatment-resistant depression, Panic disorder, PTSD, VC, Anxiety, TRD, AI, MDD, Workforce, GLOBE, Patient, Chrono, Aggression, Depression, MADRS, Lists of diseases, Safety, Pharmaceutical industry, Ketamine

MUNICH, Germany, June 08, 2022 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), together with Develco pharma, today announced the dosing of the first patient in their second Phase 2 trial with oral prolonged-release Ketamine (KET01) for Treatment-Resistant Depression.

Key Points: 
  • The trial will assess the efficacy, safety, and tolerability of add-on treatment with Ketamine hydrochloride prolonged-release tablets (KET01) in patients suffering from Treatment-Resistant depression (TRD).
  • The trial is expected to confirm the results of the previous trial, with early-onset of efficacy, showing placebo-level dissociative side effects, and excellent tolerability, furthering the take-at-home potential of this novel treatment.
  • The Ketabon program, which is a joint venture between HMNC Brain Health and Swiss-based Develco Pharma, funded the trial.
  • Clinical development of oral prolonged-release Ketamine could also be potentially expanded into other indications, such as anxiety, aggression, PTSD, and panic disorder.

HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD), suggesting antidepressant efficacy and showing Placebo-Level Dissociative Side Effects in Phase 2 oral prolonged-release Ketamine (KET01)

Retrieved on: 
Thursday, March 31, 2022
University of Zurich, Company, University, Aggression, MDD, Social psychiatry, Analgesic, Clinical trial, Treatment-resistant depression, Human, Lists of diseases, PTSD, Addiction, Coronavirus Scientific Advisory Board (Turkey), Ketamine, SCOPE, Psychiatry, Workforce, Grammatical mood, Safety, TRD, Chrono, VC, COVID-19, GLOBE, CRO, Anxiety, Department, Depression, Biozentrum University of Basel, Panic disorder, Patient, Major depressive disorder, Partnership, Pharmaceutical industry, MADRS, Schizophrenia, Psychotherapy

Potential first-in-class oral prolonged-release formulation of ketamine, KET01, suggests larger improvement in Montgomery-sberg Depression Rating Scale (MADRS) scores at 15 days compared to placebo.

Key Points: 
  • Potential first-in-class oral prolonged-release formulation of ketamine, KET01, suggests larger improvement in Montgomery-sberg Depression Rating Scale (MADRS) scores at 15 days compared to placebo.
  • Importantly, safety results from the trial demonstrated that KET01 was well tolerated, with no treatment-related serious adverse events reported.
  • The Ketabon program, a joint venture between HMNC Brain Health and Develco Pharma in Switzerland comprises an oral prolonged-release formulation of ketamine for TRD with minimal dissociative side effects.
  • Clinical development of oral prolonged-release ketamine could also be potentially expanded into other indications, such as anxiety, aggression, PTSD, and panic disorder.

Chrono.Tech Closes $30 Million Funding Round Led By Venture Capitalist Mark Carnegie

Retrieved on: 
Thursday, January 27, 2022
Crypto, Risk, Commission on European Family Law, Industry, TIME, Time, Tech, Growth, Chrono, CGU, Solution, HR, CEO, Cryptocurrency

The funding round was led by Australian venture capitalist Mark Carnegie and a leading European Family Office.

Key Points: 
  • The funding round was led by Australian venture capitalist Mark Carnegie and a leading European Family Office.
  • As a professional venture capitalist with over 30 years' experience as an entrepreneur, investor and corporate adviser in New York, London and Sydney, Mark Carnegie has previously worked with Chrono.Tech founder Sergei Sergienko, co-founding the Crypto Gaming United startup and two digital assets managed investment funds.
  • The company is also engaged in decentralized gaming, promoting the Crypto Gaming United (CGU) product based on the newfangled Play-to-Earn model.
  • Co-founded by Mark Carnegie, CGU raised over $17 million in October of last year.

Mayflower Entertainment: Action Adventure Game "Elementite" Out Now

Retrieved on: 
Wednesday, January 19, 2022
Electricity, Weapon, Unreal Engine, RPG, Firearm, Freedom, Ice, Element, Chrono, Time, Immunity, Telescopic sight, Vitality, Agility

-In shooter mode, Chrono can use up to 4 firearms at the same time that fire shots imbued with the 4 elements fire, ice, electric and poison.

Key Points: 
  • -In shooter mode, Chrono can use up to 4 firearms at the same time that fire shots imbued with the 4 elements fire, ice, electric and poison.
  • As Elementite gives enemies the power of element damage immunity, the player must switch weapons to shoot the enemy using his weak point element.
  • - An open world with several primary and secondary missions and the freedom to play the level as many times asthe player wants.
  • Skill trees to develop your character in a way that adapts tothe playstyle.

Mayflower Entertainment: Action Adventure Game "Elementite" Out Now

Retrieved on: 
Wednesday, January 19, 2022
Electricity, Weapon, Unreal Engine, RPG, Firearm, Freedom, Ice, Element, Chrono, Time, Immunity, Telescopic sight, Vitality, Agility

SEOUL, South Korea, Jan. 19, 2022 /PRNewswire/ -- Published by Mayflower Entertainment, Elementite is a third-person shooter RPG that fuses natural elements and futuristic firearms in a vast chaotic open world of challenges and secrets in a way never seen before. Users control Chrono, a combatant who has the unique ability to control the time element, allowing him to control battles using close-quarter combat skills and to finish off enemies with a heavy arsenal of firearms imbued with natural elements. Use fire, ice, electricity, and poison to unleash an incredible amount of combat combinations and strategies to overcome your opponents, while experiencing the ultra-realistic graphics powered by the Unreal Engine with Ray Tracing.

Key Points: 
  • -In shooter mode, Chrono can use up to 4 firearms at the same time that fire shots imbued with the 4 elements fire, ice, electric and poison.
  • As Elementite gives enemies the power of element damage immunity, the player must switch weapons to shoot the enemy using his weak point element.
  • - An open world with several primary and secondary missions and the freedom to play the level as many times asthe player wants.
  • Skill trees to develop your character in a way that adapts tothe playstyle.

Sm-ART NFT adds new luxurious Patek Philippe watch to its portfolio of tokenised investment opportunities

Retrieved on: 
Monday, September 27, 2021
Ethereum, ERC20, CTO, Patek Philippe SA, Collection, Ownership, CEO, NFT, Non-fungible token, Investment, Digital, Photography, Chrono, Clockmaker, Cryptocurrency

The Patek Philippe Nautilus collection is the epitome of sophisticated sports watch design.

Key Points: 
  • The Patek Philippe Nautilus collection is the epitome of sophisticated sports watch design.
  • Sm-ART NFT will be offering fractional ownership of this Patek Phillipe Nautilus 5711/1A-010 stainless steel watch estimated to be worth more than $100,000.
  • Danny Sangha, co-founder and CTO of Sm-ART NFT, said:
    "We are delighted to have added this stunning Patek Phillipe watch to our collection of luxury assets.
  • The full collection of assets, including its Patek Phillipe watch, can be viewed here: https://sm-artnft.com/#section-assets .

Sm-ART NFT adds new luxurious Patek Philippe watch to its portfolio of tokenised investment opportunities

Retrieved on: 
Monday, September 27, 2021
Ethereum, ERC20, CTO, Patek Philippe SA, Collection, Multimedia, Ownership, CEO, NFT, Non-fungible token, Investment, Digital, Photography, Chrono, Clockmaker, Cryptocurrency

The Patek Philippe Nautilus collection is the epitome of sophisticated sports watch design.

Key Points: 
  • The Patek Philippe Nautilus collection is the epitome of sophisticated sports watch design.
  • Sm-ART NFT will be offering fractional ownership of this Patek Phillipe Nautilus 5711/1A-010 stainless steel watch estimated to be worth more than $100,000.
  • Sm-ART NFT allows investors to purchase fractional shares in high value and unique items via blockchain ownership.
  • Danny Sangha, co-founder and CTO of Sm-ART NFT, said:
    "We are delighted to have added this stunning Patek Phillipe watch to our collection of luxury assets.